VEGFA and neoplasm: Inhibit the H22 tumor growth through anti-angiogenesis induced by VEGF signaling pathway blocking. (The volume of tumors of nanoparticle-treated group and control group was 1.12 ± 0.12 and 2.36 ± 0.32 cm3)